Axa Health is rolling out additional testing and treatment options across its men’s health, women’s health, fertility, pregnancy and early parenthood and menopause support services in collaboration with Peppy.
These tests include men’s ultimate blood test, polyendocrine metabolic ovarian syndrome (PMOS) testing, personalised hormone replacement therapy (HRT) prescribing and treatment plans, semen testing, cholesterol testing, and prostate specific-antigen (PSA) testing,
The services also now include access to private prescriptions for HRT, contraception and men’s health treatments when clinically appropriate.
All services are delivered by Peppy’s qualified clinical practitioners and come at no additional charge and are included within Axa Health’s existing standalone company paid men’s health, women’s health, fertility, pregnancy and early parenthood and menopause support services.
Rich Glassborow, distribution, propositions and marketing director at Axa Health, (pictured) said: “These initiatives and enhancements demonstrate our ongoing commitment to prioritising employee wellbeing and ensuring people receive timely, expert support when they most need it.
“By adding access to tests, treatment options and private prescriptions, we’re helping our clients’ employees get answers sooner, start the right treatment earlier and feel listened to and cared for throughout their health journey.”
